Cardiac Biomarkers Market Size, Share, Trends & Forecast
The Cardiac Biomarkers Market is experiencing strong growth as healthcare providers increasingly rely on biomarker testing for the early detection and management of cardiovascular diseases. Market Research Future estimates that the market was valued at USD 19.2 billion in 2024 and is projected to reach USD 66.93 billion by 2035, registering a CAGR of 12.02% during 2025–2035.
Cardiac biomarkers such as troponins, creatine kinase, myoglobin, and natriuretic peptides provide important information about cardiac injury and function. Their growing use in emergency departments, hospitals, diagnostic laboratories, and point-of-care settings is supporting market expansion.
The increasing prevalence of cardiovascular diseases is a major factor driving demand. Improved awareness of heart health and greater emphasis on early diagnosis are also encouraging healthcare providers to adopt advanced biomarker testing technologies.